GU; Chong-Hui

Patent Applications and Registrations

Patent applications and USPTO patent grants for GU; Chong-Hui.The latest application filed is for "pharmaceutical composition and administrations thereof".

Company Profile

7.13.24

GU; Chong-Hui - Waban MA
Gu; Chong-Hui - Weban MA
Gu; Chong-Hui - North Brunswick NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Composition And Administrations Thereof App 20220241206 - DOKOU; Eleni ; et al.	2022-08-04
Tablet compositions Grant 11,389,454 - Bhat , et al. July 19, 2	2022-07-19
Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same Grant 11,345,677 - Lane , et al. May 31, 2	2022-05-31
Ivosidenib Forms And Pharmaceutical Compositions App 20210323944 - GU; Chong-Hui ; et al.	2021-10-21
Pharmaceutical composition and administrations thereof Grant 11,147,770 - Dokou , et al. October 19, 2	2021-10-19
Cocrystals, Pharmaceutical Compositions Thereof, And Methods Of Treatment Involving Same App 20210198234 - LANE; Benjamin S. ; et al.	2021-07-01
Therapeutically Active Compounds And Their Methods Of Use App 20210155603 - Agresta; Samuel V. ; et al.	2021-05-27
Pharmaceutical Compositions Of Therapeutically Active Compounds App 20200397768 - Gu; Chong-Hui	2020-12-24
Pharmaceutical compositions of therapeutically active compounds Grant 10,799,490 - Gu October 13, 2	2020-10-13
Therapeutically active compounds and their methods of use Grant 10,730,854 - Agresta , et al.	2020-08-04
Pharmaceutical Compositions Of Therapeutically Active Compounds App 20190336487 - Gu; Chong-Hui	2019-11-07
Pharmaceutical compositions of therapeutically active compounds Grant 10,449,184 - Gu Oc	2019-10-22
Pharmaceutical Composition And Administrations Thereof App 20190274959 - DOKOU; Eleni ; et al.	2019-09-12
Pharmaceutical composition and administrations thereof Grant 10,272,046 - Dokou , et al.	2019-04-30
Therapeutically Active Compounds And Their Methods Of Use App 20180370951 - Agresta; Samuel V. ; et al.	2018-12-27
Pharmaceutical Compositions Of Therapeutically Active Compounds App 20180325880 - Gu; Chong-Hui	2018-11-15
Therapeutically active compounds and their methods of use Grant 10,093,654 - Agresta , et al. October 9, 2	2018-10-09
Pharmaceutical compositions of therapeutically active compounds Grant 9,968,595 - Gu May 15, 2	2018-05-15
Tablet Compositions App 20180064715 - Bhat; Sreenivas S. ; et al.	2018-03-08
Therapeutically Active Compounds And Their Methods Of Use App 20170305885 - Agresta; Samuel V. ; et al.	2017-10-26
Therapeutically active compounds and their methods of use Grant 9,738,625 - Agresta , et al. August 22, 2	2017-08-22
Pharmaceutical Composition And Administrations Thereof App 20170100340 - DOKOU; Eleni ; et al.	2017-04-13
Pharmaceutical Compositions Of Therapeutically Active Compounds App 20170014396 - Gu; Chong-Hui	2017-01-19
Pharmaceutical Compositions Of Therapeutically Active Compounds App 20170007661 - Gu; Chong-Hui	2017-01-12
Therapeutically Active Compounds And Their Methods Of Use App 20160194305 - AGRESTA; Samuel V. ; et al.	2016-07-07
Pharmaceutical Composition And Administrations Thereof App 20150246031 - Dokou; Eleni ; et al.	2015-09-03
Pharmaceutical Composition And Administrations Thereof App 20150024047 - Dokou; Eleni ; et al.	2015-01-22
Pharmaceutical composition and administrations thereof Grant 8,883,206 - Dokou , et al. November 11, 2	2014-11-11
Pharmaceutical Composition And Administrations Thereof App 20140255483 - Dokou; Eleni ; et al.	2014-09-11
Pharmaceutical Composition And Administrations Thereof App 20130224293 - DOKOU; ELENI ; et al.	2013-08-29
Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphon- ooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine Grant 7,851,476 - Chen , et al. December 14, 2	2010-12-14
Formulations Of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl- )-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione App 20100292246 - Gu; Chong-Hui ; et al.	2010-11-18
Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl- )-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dione Grant 7,829,711 - Matiskella , et al. November 9, 2	2010-11-09
Crystalline Materials Of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl- )-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione App 20090227794 - Matiskella; John D. ; et al.	2009-09-10
Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphon- ooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine App 20070155702 - Chen; Chung-Pin H. ; et al.	2007-07-05
Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl- )-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione App 20060100209 - Gu; Chong-Hui ; et al.	2006-05-11
Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl- )-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione App 20060100432 - Matiskella; John D. ; et al.	2006-05-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.